SK14502000A3 - Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu - Google Patents

Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu Download PDF

Info

Publication number
SK14502000A3
SK14502000A3 SK1450-2000A SK14502000A SK14502000A3 SK 14502000 A3 SK14502000 A3 SK 14502000A3 SK 14502000 A SK14502000 A SK 14502000A SK 14502000 A3 SK14502000 A3 SK 14502000A3
Authority
SK
Slovakia
Prior art keywords
reboxetine
pindolol
patient
disorder
administered
Prior art date
Application number
SK1450-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Duncan Paul Taylor
Original Assignee
Pharmacia And Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia And Upjohn Company filed Critical Pharmacia And Upjohn Company
Publication of SK14502000A3 publication Critical patent/SK14502000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1450-2000A 1998-05-08 1999-04-14 Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu SK14502000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8486098P 1998-05-08 1998-05-08
PCT/US1999/006523 WO1999058130A1 (en) 1998-05-08 1999-04-14 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol

Publications (1)

Publication Number Publication Date
SK14502000A3 true SK14502000A3 (sk) 2001-05-10

Family

ID=22187677

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1450-2000A SK14502000A3 (sk) 1998-05-08 1999-04-14 Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu

Country Status (22)

Country Link
EP (1) EP1075264B1 (de)
JP (1) JP2002514601A (de)
KR (1) KR20010052319A (de)
CN (1) CN1300217A (de)
AT (1) ATE283694T1 (de)
AU (1) AU764579B2 (de)
BR (1) BR9909559A (de)
CA (1) CA2326105A1 (de)
DE (1) DE69922367T2 (de)
EA (1) EA003469B1 (de)
ES (1) ES2232128T3 (de)
HU (1) HUP0101341A3 (de)
IL (1) IL139211A0 (de)
NO (1) NO20005621D0 (de)
NZ (1) NZ508035A (de)
PL (1) PL345351A1 (de)
PT (1) PT1075264E (de)
SI (1) SI1075264T1 (de)
SK (1) SK14502000A3 (de)
TR (1) TR200003262T2 (de)
WO (1) WO1999058130A1 (de)
ZA (1) ZA200005301B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459751B1 (de) * 1999-07-01 2005-09-14 Pharmacia & Upjohn Company LLC (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ES2246488T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC Reboxetina para tratar la migraña.
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
EP1551393A4 (de) 2002-07-30 2010-06-16 Peter Migaly Kombinationstherapie gegen depression, prävention von suizid und verschiedener medizinischer und psychiatrischer erkrankungen
NZ556779A (en) 2002-12-27 2008-12-24 Otsuka Pharma Co Ltd Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
US20120077818A1 (en) * 2009-05-13 2012-03-29 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response

Also Published As

Publication number Publication date
SI1075264T1 (en) 2005-06-30
BR9909559A (pt) 2000-12-19
NO20005621L (no) 2000-11-07
NO20005621D0 (no) 2000-11-07
AU764579B2 (en) 2003-08-21
ZA200005301B (en) 2001-10-01
PT1075264E (pt) 2005-01-31
EA200001162A1 (ru) 2001-04-23
EP1075264B1 (de) 2004-12-01
WO1999058130A1 (en) 1999-11-18
DE69922367D1 (de) 2005-01-05
CN1300217A (zh) 2001-06-20
KR20010052319A (ko) 2001-06-25
DE69922367T2 (de) 2005-12-22
JP2002514601A (ja) 2002-05-21
CA2326105A1 (en) 1999-11-18
AU3546099A (en) 1999-11-29
ES2232128T3 (es) 2005-05-16
TR200003262T2 (tr) 2001-03-21
PL345351A1 (en) 2001-12-17
NZ508035A (en) 2004-02-27
ATE283694T1 (de) 2004-12-15
HUP0101341A3 (en) 2006-07-28
EA003469B1 (ru) 2003-06-26
IL139211A0 (en) 2001-11-25
EP1075264A1 (de) 2001-02-14
HUP0101341A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
SK286864B6 (sk) Použitie opticky čistého (S,S) reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu fibromyalgie alebo iných somatoformných porúch
ES2260195T3 (es) Metodos de producir (r)-y (s)-didesmetil-sibutramina opticamente pura.
US20060211686A1 (en) Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions
HUP0003410A2 (hu) Azapoliciklusos vegyületeket tartalmazó kombinációs gyógyszerkészítmények emlősök nikotinélvezetének megelőzésére és kezelésére
ES2244189T3 (es) Uso de reboxetina para el tratamiento de trastornos neuropsiquiatricos.
US20070149527A1 (en) New treatments for nervous disorders
US6500827B2 (en) Drug combinations
AU764579B2 (en) New drug combinations of a N.A.R.I., preferably reboxetine, and pindolol
EP1071418B1 (de) Neue behandlungen für nervenkrankheiten
CZ20004067A3 (cs) Nové kombinace léků N.A.R.I.(inhibitory reaktivace noradrenalinu), s výhodou reboxetinu, a pinodolu
MXPA00010945A (en) New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
MXPA00009883A (en) New treatments for nervous disorders
MXPA00010025A (en) New treatments for nervous disorders
HK1036592A (en) New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol